Skip to main content
. 2022 Nov 13;27(22):7825. doi: 10.3390/molecules27227825

Figure 1.

Figure 1

Effect of azilsartan on the viability of MCF-7 and MDA-MB-231 breast cancer cell lines and MCF 10A breast normal epithelial cells. (A,C,E) Representative images of the MCF-7, MDA-MB-231 and MCF 10A cell lines, respectively, before and after treatment with azilsartan at different concentrations for 48 h. (B,D,F) Percentage of viability of MCF-7, MDA-MB-231 and MCF 10A cell lines, respectively, after treatment with azilsartan for 48 h at different concentrations. Data represent mean ± SD, n = 3. Significant difference was analyzed by one-way ANOVA, where: ** p < 0.01, *** p < 0.001, compared to untreated cells.